LA HB622

Creates an advisory board within the Louisiana Department of Insurance to review and provide medical recommendations for approving new treatments for rare cancers

Board comprises 14 members including the Insurance Commissioner, Louisiana Department of Health officials, Surgeon General, representatives from cancer research organizations, medical schools (LSU, Tulane, Xavier Ochsner), and two oncologists specializing in rare cancer treatments

Executive director of the Louisiana Cancer Research Center serves as chairperson of the advisory board

Board must hold quarterly public meetings and submit formal written reports to the legislature within 30 days of each meeting

Insurance Commissioner is authorized to promulgate administrative rules to implement the provisions